DLB vs. CROX, TAL, MTN, MHK, LBRDA, WSC, LBRDK, AS, HAS, and PARA
Should you be buying Dolby Laboratories stock or one of its competitors? The main competitors of Dolby Laboratories include Crocs (CROX), TAL Education Group (TAL), Vail Resorts (MTN), Mohawk Industries (MHK), Liberty Broadband (LBRDA), WillScot Mobile Mini (WSC), Liberty Broadband (LBRDK), Amer Sports (AS), Hasbro (HAS), and Paramount Global (PARA). These companies are all part of the "consumer discretionary" sector.
Crocs (NASDAQ:CROX) and Dolby Laboratories (NYSE:DLB) are both mid-cap consumer discretionary companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, valuation, media sentiment, earnings, analyst recommendations, profitability, risk and community ranking.
Crocs received 191 more outperform votes than Dolby Laboratories when rated by MarketBeat users. Likewise, 59.35% of users gave Crocs an outperform vote while only 57.56% of users gave Dolby Laboratories an outperform vote.
In the previous week, Dolby Laboratories had 2 more articles in the media than Crocs. MarketBeat recorded 17 mentions for Dolby Laboratories and 15 mentions for Crocs. Dolby Laboratories' average media sentiment score of 0.59 beat Crocs' score of 0.41 indicating that Crocs is being referred to more favorably in the media.
93.4% of Crocs shares are held by institutional investors. Comparatively, 58.6% of Dolby Laboratories shares are held by institutional investors. 2.7% of Crocs shares are held by insiders. Comparatively, 39.5% of Dolby Laboratories shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Crocs has a beta of 2.01, suggesting that its share price is 101% more volatile than the S&P 500. Comparatively, Dolby Laboratories has a beta of 0.97, suggesting that its share price is 3% less volatile than the S&P 500.
Crocs currently has a consensus price target of $141.55, indicating a potential upside of 14.57%. Dolby Laboratories has a consensus price target of $98.00, indicating a potential upside of 26.30%. Given Crocs' stronger consensus rating and higher possible upside, analysts plainly believe Dolby Laboratories is more favorable than Crocs.
Crocs has a net margin of 20.00% compared to Crocs' net margin of 14.70%. Dolby Laboratories' return on equity of 61.97% beat Crocs' return on equity.
Crocs has higher revenue and earnings than Dolby Laboratories. Crocs is trading at a lower price-to-earnings ratio than Dolby Laboratories, indicating that it is currently the more affordable of the two stocks.
Summary
Crocs beats Dolby Laboratories on 13 of the 19 factors compared between the two stocks.
Get Dolby Laboratories News Delivered to You Automatically
Sign up to receive the latest news and ratings for DLB and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding DLB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Dolby Laboratories Competitors List
Related Companies and Tools
